PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+10.75%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$3.81B
AUM Growth
+$3.81B
(+7.3%)
Cap. Flow
-$38.8M
Cap. Flow
% of AUM
-1.02%
Top 10 Holdings %
Top 10 Hldgs %
49.66%
Holding
154
New
23
Increased
21
Reduced
32
Closed
26
Top Buys
| 1 |
Verrica Pharmaceuticals
VRCA
|
$67.3M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$55.8M |
| 3 |
MeiraGTx Holdings
MGTX
|
$53.9M |
| 4 |
Intuitive Surgical
ISRG
|
$43.1M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$33.7M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$121M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$50.9M |
| 3 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$34.2M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$30.9M |
| 5 |
AnaptysBio
ANAB
|
$24.7M |
Sector Composition
| 1 | Healthcare | 92.89% |
| 2 | Industrials | 0.65% |
| 3 | Consumer Discretionary | 0.05% |
| 4 | Technology | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$13.8B
| $463M | 12.14% | 4,715,250 -46,739 | -1% | -$4.59M |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $313M | 8.2% | 20,024,424 | – | – |
|
|
GBT
3
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $218M | 5.72% | 4,828,910 -160,156 | -3% | -$7.24M |
|
|
4
Alnylam Pharmaceuticals
ALNY
$58.5B
| $182M | 4.77% | 1,846,911 +566,109 | +44% | +$55.8M |
|
|
ZGNX
5
DELISTED
Zogenix, Inc.
ZGNX
| $175M | 4.6% | 3,970,357 | – | – |
|
|
LJPC
6
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $126M | 3.3% | 4,313,611 | – | – |
|
|
BHVN
7
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $108M | 2.84% | 2,743,647 -183,802 | -6% | -$7.26M |
|
|
DOVA
8
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $93.5M | 2.45% | 3,125,851 +344,874 | +12% | +$10.3M |
|
9
Iovance Biotherapeutics
IOVA
$807M
| $74.9M | 1.96% | 5,852,202 -310,000 | -5% | -$3.97M |
|
|
XLRN
10
DELISTED
Acceleron Pharma Inc.
XLRN
| $74.1M | 1.94% | 1,528,205 +11,946 | +0.8% | +$580K |
|
11
Ascendis Pharma
ASND
$11.8B
| $71.4M | 1.87% | 1,072,647 +90,000 | +9% | +$5.99M |
|
|
12
Verrica Pharmaceuticals
VRCA
$52.8M
| $67.3M | 1.76% | +3,410,412 | New | +$67.3M |
|
13
Regenxbio
RGNX
$451M
| $62.2M | 1.63% | 867,106 -14,000 | -2% | -$1M |
|
|
BPMC
14
DELISTED
Blueprint Medicines
BPMC
| $61M | 1.6% | 961,147 -69,287 | -7% | -$4.4M |
|
|
ALBO
15
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $60.5M | 1.59% | 1,704,330 | – | – |
|
|
ALXN
16
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $57.5M | 1.51% | 463,450 -410,000 | -47% | -$50.9M |
|
17
Travere Therapeutics
TVTX
$1.56B
| $57.4M | 1.5% | 3,212,871 | – | – |
|
18
Merit Medical Systems
MMSI
$5.36B
| $55.4M | 1.45% | 1,082,013 +37,000 | +4% | +$1.89M |
|
19
uniQure
QURE
$896M
| $54.6M | 1.43% | 1,444,628 +50,000 | +4% | +$1.89M |
|
|
MYOK
20
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $54.1M | 1.42% | 1,089,169 +254,490 | +30% | +$12.6M |
|
|
21
MeiraGTx Holdings
MGTX
$587M
| $53.9M | 1.41% | +4,703,398 | New | +$53.9M |
|
|
KDMN
22
DELISTED
Kadmon Holdings, Inc.
KDMN
| $52.5M | 1.38% | 13,165,746 +8,000,000 | +155% | +$31.9M |
|
|
QTNT
23
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $52.1M | 1.36% | 6,483,020 +450,000 | +7% | +$3.61M |
|
|
CORI
24
DELISTED
Corium International, Inc.
CORI
| $50.9M | 1.34% | 6,357,133 | – | – |
|
|
25
Intuitive Surgical
ISRG
$170B
| $47.8M | 1.25% | 100,000 +90,000 | +900% | +$43.1M |
|